Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: VGX-1027 To Undergo Additional Testing For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
Juvenile-Onset Dermatomyositis Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity
Medicine, 03/20/08
Print     Email This Article     Save in My Library   Free Abstract
Bingham A et al. - Certain Dermatomyositis (DM) pts with a severe, prolonged clinical course and a high frequency of calcinosis appear to be at greater risk for the development Lipodystrophy (LD). Further study is warranted to investigate the pathogenesis of acquired LD in pts with DM.

Methods
  • This study describes the clinical features of 28 pts with juvenile dermatomyositis (JDM) and 1 patient with adult-onset DM

Results
  • All pts developed LD that could be categorized into generalized, partial, or focal, based on the pattern of fat loss distribution
  • LD onset was often delayed, beginning at 4.6 y after diagnosis of DM
  • Calcinosis, muscle atrophy, joint contractures, and facial rash were DM disease features found to be associated with LD
  • Panniculitis was associated with focal lipoatrophy while the anti-p155 autoantibody, was more associated with generalized LD
  • Specific LD features such as acanthosis nigricans, hirsutism, fat redistribution, and steatosis/nonalcoholic steatohepatitis were frequent in pts with LD
  • Insulin resistance and hypertriglyceridemia was recognized in pts with generalized and partial LD
  • Regional fat loss was more frequent in generalized than in partial LD and absent from DM pts w/o LD
  • Cytokine polymorphisms, the C3 nephritic factor, insulin receptor antibodies, and lamin mutations did not appear to play a pathogenic role in the development of LD in these pts

Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.